Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.

Journal of Parasitology Research, published by HINDAWI LTD, is a pivotal open-access journal that has been disseminating groundbreaking research in the field of parasitology since 2009. With an ISSN of 2090-0023 and an E-ISSN of 2090-0031, this journal strives to provide researchers, professionals, and students with accessible and high-impact studies that advance understanding of parasitic diseases and their epidemiology. The journal currently holds a Q3 ranking in Infectious Diseases and a Q2 ranking in Parasitology, indicating its significant contribution to the academic community. Furthermore, with a Scopus ranking placing it at #39 in Parasitology and #186 in Infectious Diseases, it plays an essential role in shaping research directions in these fields. As an open-access journal, Journal of Parasitology Research enhances the visibility and accessibility of published works, ensuring crucial findings reach a global audience. With a focus on innovative research, the journal welcomes submissions that explore both theoretical frameworks and practical applications in parasitology, making it an invaluable resource for those dedicated to combating parasitic infections.

PARASITOLOGY, published by Cambridge University Press, is a prestigious journal that has been at the forefront of research in the field of parasitology since its inception in 1908. This esteemed publication carries the ISSN 0031-1820 and E-ISSN 1469-8161, and its rigorous peer-reviewed articles provide insights into both fundamental and applied aspects of parasitic biology, infectious diseases, and host-parasite interactions. With a commendable impact factor, PARASITOLOGY ranks in the top quartile (Q1) for Animal Science and Zoology and holds Q2 rankings in both Infectious Diseases and Parasitology categories, indicating its significant influence and contribution to these disciplines. The journal's diverse scope allows for a broad range of research articles, reviews, and case studies, making it an essential resource for researchers, professionals, and students seeking to stay updated on the latest developments in the field. Based in the United Kingdom, PARASITOLOGY offers valuable access to critical research in an era where understanding parasitic diseases is more vital than ever, and continues to shape the future of this important scientific field.

MOLECULAR AND BIOCHEMICAL PARASITOLOGY is a renowned journal published by Elsevier, focusing on the crucial intersections of molecular biology and parasitology. Since its inception in 1980, this journal has aimed to advance our understanding of parasitic organisms at the biochemical and molecular levels, providing a dedicated platform for researchers studying host-parasite interactions, parasite genetics, and diagnostic methodologies. Although it currently holds a quartile status of Q4 in Molecular Biology and Q3 in Parasitology for the year 2023, it remains a vital resource within the academic community, boasting a variety of research articles, reviews, and case studies that explore innovative treatment strategies and the molecular biology of parasites. Researchers and students alike can benefit from the journal's contributions to the field, despite its traditional publishing model, as the content remains pivotal for ongoing studies and advancements in parasitology.

PARASITE IMMUNOLOGY, published by Wiley, is a leading journal in the field of immunology and parasitology, with an ISSN of 0141-9838 and E-ISSN of 1365-3024. Since its inception in 1979, it has played a pivotal role in advancing our understanding of host-parasite interactions, immunological responses to parasitic infections, and the mechanisms of immunological resistance. The journal is adeptly positioned within the academic community, currently holding a prestigious Q2 ranking in Parasitology and a Q3 ranking in Immunology for 2023, indicating its significant influence and relevance. Its comprehensive scope attracts a diverse readership, contributing to the discourse surrounding novel therapeutic approaches and emerging challenges in parasitic diseases. With a consistent convergence of research until 2024, PARASITE IMMUNOLOGY is an essential resource for researchers, professionals, and students seeking to deepen their knowledge and foster collaboration in these dynamic fields. Although it is not an open-access journal, the insights shared within its pages are invaluable for shaping future research trajectories.

EXPERIMENTAL PARASITOLOGY, published by Academic Press Inc Elsevier Science, is a prominent journal in the domains of immunology, infectious diseases, and parasitology, with roots extending back to 1951. This journal, bearing the ISSN 0014-4894 and E-ISSN 1090-2449, serves as a critical conduit for sharing advancements in the understanding of parasite biology, host-parasite interactions, and the immunological responses elicited by parasitic infections. Although it currently operates under a subscription model without open access options, its rigorous scholarly content is vital for researchers and practitioners alike looking to stay informed on the latest developments and applications in the field. With a recent categorization as Q3 in key scientific categories, including Infectious Diseases and Parasitology, and a Scopus ranking solidifying its relevance, EXPERIMENTAL PARASITOLOGY is an essential resource for those committed to advancing knowledge and solutions to parasitic diseases.

Food and Waterborne Parasitology is a premier open-access journal published by ELSEVIER, dedicated to the critical study of parasites affecting food and water safety. Since its inception in 2015, the journal has significantly contributed to research in the fields of epidemiology, food science, and parasitology, achieving impressive rankings in its categories with a Q1 status in Food Science and a Q2 in both Epidemiology and Parasitology as of 2023. Addressed from RADARWEG 29, 1043 NX Amsterdam, Netherlands, it garners attention for its accessible content, aiming to elevate the understanding of the impact of parasitic organisms on public health and food security. With its open-access model, the journal enhances visibility and dissemination of research findings, fostering collaboration and innovation among researchers, professionals, and students alike. By bridging scientific inquiry with practical applications, Food and Waterborne Parasitology plays a pivotal role in addressing global health challenges and advancing knowledge in this vital area of study.

Parasitology International, published by Elsevier Ireland Ltd, is a leading journal in the field of parasitology and infectious diseases. With its ISSN 1383-5769 and E-ISSN 1873-0329, this esteemed journal provides a platform for the dissemination of high-quality research covering various aspects of parasitic diseases and their treatment. Recognized for its rigorous peer-review process, Parasitology International currently holds a commendable Q2 ranking in both the Infectious Diseases and Parasitology categories for 2023. The journal's Scopus rankings further enhance its reputation, positioning it at Rank #33/79 in Parasitology and Rank #166/344 in Infectious Diseases. Covering a broad range of topics from host-parasite interactions to novel treatments, this journal plays a pivotal role in advancing knowledge and fostering innovation within the research community. Though it does not currently operate as an open access journal, it continues to attract contributions from leading experts around the world, making it an invaluable resource for researchers, professionals, and students committed to understanding and combating parasitic diseases.

PARASITOLOGY RESEARCH, published by Springer, stands as a pivotal journal in the fields of parasitology, infectious diseases, and insect science, with a rich history dating back to 1987. Operating from Germany, this journal has garnered an impressive reputation, achieving a high ranking within various categories, including Q1 in Veterinary (miscellaneous) and Q2 across several relevant fields as of 2023. While it does not currently offer Open Access options, the journal remains a vital resource for researchers, professionals, and students seeking to contribute to and keep pace with advancements in parasitological studies. With a commitment to publishing high-quality research, PARASITOLOGY RESEARCH serves as an essential forum for disseminating findings that enhance our understanding of parasitic organisms and their impacts on health and the environment. Explore this journal to engage with cutting-edge investigations and reviews that drive innovation in parasitology and related disciplines.

Parasite Epidemiology and Control is a premier open-access journal published by Elsevier, dedicated to advancing the understanding of parasites and their impact on public health. Since its inception in 2016, the journal has established itself as a prominent publication in the fields of epidemiology, infectious diseases, and parasitology, achieving a commendable classification of Q2 in these categories as per 2023 metrics. With its ISSN 2405-6731, the journal serves as a vital resource for researchers, practitioners, and students, offering rigorous, peer-reviewed articles that illuminate parasite-related epidemiological trends and control strategies. Based in the United Kingdom, Parasite Epidemiology and Control actively promotes open access, ensuring that crucial research findings are readily accessible to a global audience, thus enhancing collaborative efforts in tackling parasitic diseases. The journal's impact is reflected in its Scopus rankings—ranking 17th in Parasitology among 79 journals, 47th in Epidemiology among 148, and 121st in Infectious Diseases among 344—underlining its significance in the scientific community. Join us in exploring this critical field and contributing to the fight against parasitic diseases through innovative research and shared knowledge.